WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9301 Infant (under 12 months) mortality rate: 492
GDP / capita (US$): 2'2651 Child (under 5 years) mortality rate: 732

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 45'546  44'354  43'178  42'028  40'909  31'285  23'446  16'268 
Births 1'564  1'550  1'535  1'520  1'503  1'211  988  807 
Surviving infants 1'486  1'471  1'455  1'438  1'420  1'124  920  747 
Pop. less than 5 years 7'136  7'048  6'956  6'855  6'742  5'107  4'457  3'347 
Pop. less than 15 years 19'146  18'728  18'295  17'854  17'413  13'816  11'482  8'129 
Female 15-49 years 11'078  10'766  10'468  10'183  9'911  7'526  5'078  3'374 

Number of reported case

(Click for retrospective incidence data for Kenya)
Diphtheria 15  6'395 
Japanese encephalitis
Measles 354  190  2'395  95  21'002  77'072  28'473 
Mumps 30'468 
Pertussis 424  7'404  13'281 
Polio* 14  1'528  455 
Rubella 651  299  610  473 
Rubella (CRS)
Tetanus (neonatal) 36  1'278  1'612 
Tetanus (total)** 36  1'278  1'692  831 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kenya)
Vaccine year result method % card seen                                                
BCG 2007  96  DHS   70  81  95  84  92  99  75  54 
DTP1 2007  96  DHS   70  88  84  89  95  93  73 
DTP3 2007  86  DHS   70  81  84  83  88  83  63  42 
HepB_BD          88 
HepB3 2007  86  DHS   70  81  83  88  83 
Hib3 2007  86  DHS   70  81  83  88  83 
JapEnc         
MCV          79  79  93  87  86  46  41 
MCV2         
PCV1          88  88  88  99* 
PCV3          81  84  82  85 
Pol3 2007  88  DHS   70  81  84  82  88  83  62  44 
Rota1          62 
Rota_last          38 
Rubella1         
TT2plus 2003  52  DHS   60  55  77  76  72  51  45 
PAB         
VAD1          23  80  22  33  18 
YFV 2007  DHS   70  30  57  66  56  36  11 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kenya)
BCG 79  84  92  99  91  92 
DTP1 82  89  95  93  83  92 
DTP3 76  83  88  83  82  84 
HepB3 83  83  88  83 
HepB_BD
Hib3 83  83  88  83 
MCV 93  93  87  86  78  78 
MCV2
PAB 73  73  73  78  68  60 
PCV3 75  82  85 
Pol3 82  82  88  83  80  84 
Rota_last
YFV

Number of districts in the country 286  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 26
From 80 to 89% 20
From 50 to 79% 43
Less than 50% 10
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6,10,14 weeks; Yes
HPV 9-13 years (2 doses); No Grade 4 (9-13 years) girls
IPV 14 weeks; Yes From July 2015
Measles 9, 18 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6-11, 12-59 months; Yes
YF 9 months; No

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2017  2014-2018  2012-2017  2010-2015  2011 -2015    2005 - 2010 
Nº of districts with microplans that include activities to raise immunization coverage number 286  288      149  149  78 

System performance

Total Nº districts in country number 286  285  203  153  149  149  78 
Nº districts with DTP3 coverage >=80% number 133  128  108  104  88  62  34 
% of districts with DTP3 coverage >=80% From 0 to 100% 47  45  53  68  59  42  44 
Nº districts with measles (MCV1) coverage >=95% number 61  46  71  49  45  26  13 
% of districts with MCV1 coverage >=95% From 0 to 100% 21  16  35  32  30  17  17 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 14  15    88  85  10  90 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.